Literature DB >> 2511001

The smaller human VH gene families display remarkably little polymorphism.

I Sanz1, P Kelly, C Williams, S Scholl, P Tucker, J D Capra.   

Abstract

We report the nucleotide sequence of 30 distinct human VH gene segments from the VHIV, VHV and VHVI gene families. When these sequences were compared to previously published sequences from these smaller human VH families a surprisingly low level of polymorphism was noted. Two VHIV gene segments from unrelated individuals were identical to two previously published VHIV sequences. Five VHV sequences were identical and seven VHVI gene segments were identical. Where differences were found between the sequences, allele specific oligonucleotide probes were used to verify the germline nature of the change and to test for segregation in several large kindreds. These data provide evidence that at least some human VH gene segments are remarkably stable.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2511001      PMCID: PMC402059          DOI: 10.1002/j.1460-2075.1989.tb08550.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  33 in total

1.  One heavy chain variable region gene segment subfamily in the BALB/c mouse contains 500-1000 or more members.

Authors:  D Livant; C Blatt; L Hood
Journal:  Cell       Date:  1986-11-07       Impact factor: 41.582

2.  Organization and evolution of variable region genes of the human immunoglobulin heavy chain.

Authors:  M Kodaira; T Kinashi; I Umemura; F Matsuda; T Noma; Y Ono; T Honjo
Journal:  J Mol Biol       Date:  1986-08-20       Impact factor: 5.469

3.  A novel family of variable region genes of the human immunoglobulin heavy chain.

Authors:  K H Lee; F Matsuda; T Kinashi; M Kodaira; T Honjo
Journal:  J Mol Biol       Date:  1987-06-20       Impact factor: 5.469

4.  Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase.

Authors:  R K Saiki; D H Gelfand; S Stoffel; S J Scharf; R Higuchi; G T Horn; K B Mullis; H A Erlich
Journal:  Science       Date:  1988-01-29       Impact factor: 47.728

5.  Relationship of human variable region heavy chain germ-line genes to genes encoding anti-DNA autoantibodies.

Authors:  H Dersimonian; R S Schwartz; K J Barrett; B D Stollar
Journal:  J Immunol       Date:  1987-10-01       Impact factor: 5.422

6.  Early restriction of the human antibody repertoire.

Authors:  H W Schroeder; J L Hillson; R M Perlmutter
Journal:  Science       Date:  1987-11-06       Impact factor: 47.728

7.  DNA sequence analysis with a modified bacteriophage T7 DNA polymerase.

Authors:  S Tabor; C C Richardson
Journal:  Proc Natl Acad Sci U S A       Date:  1987-07       Impact factor: 11.205

8.  Human heavy-chain variable region gene family nonrandomly rearranged in familial chronic lymphocytic leukemia.

Authors:  A Shen; C Humphries; P Tucker; F Blattner
Journal:  Proc Natl Acad Sci U S A       Date:  1987-12       Impact factor: 11.205

9.  A new human immunoglobulin VH family preferentially rearranged in immature B-cell tumours.

Authors:  C G Humphries; A Shen; W A Kuziel; J D Capra; F R Blattner; P W Tucker
Journal:  Nature       Date:  1988-02-04       Impact factor: 49.962

10.  Organization of the murine immunoglobulin VH complex in the inbred strains.

Authors:  G A Rathbun; J D Capra; P W Tucker
Journal:  EMBO J       Date:  1987-10       Impact factor: 11.598

View more
  56 in total

1.  Third complementarity-determining region of mutated VH immunoglobulin genes contains shorter V, D, J, P, and N components than non-mutated genes.

Authors:  K Rosner; D B Winter; R E Tarone; G L Skovgaard; V A Bohr; P J Gearhart
Journal:  Immunology       Date:  2001-06       Impact factor: 7.397

2.  Sequence analyses of three immunoglobulin G anti-virus antibodies reveal their utilization of autoantibody-related immunoglobulin Vh genes, but not V lambda genes.

Authors:  D F Huang; T Olee; Y Masuho; Y Matsumoto; D A Carson; P P Chen
Journal:  J Clin Invest       Date:  1992-12       Impact factor: 14.808

3.  Characterization of the cDNA of a broadly reactive neutralizing human anti-gp120 monoclonal antibody.

Authors:  W A Marasco; J Bagley; C Zani; M Posner; L Cavacini; W A Haseltine; J Sodroski
Journal:  J Clin Invest       Date:  1992-10       Impact factor: 14.808

4.  Germline variable region gene segment derivation of human monoclonal anti-Rh(D) antibodies. Evidence for affinity maturation by somatic hypermutation and repertoire shift.

Authors:  J M Bye; C Carter; Y Cui; B D Gorick; S Songsivilai; G Winter; N C Hughes-Jones; J D Marks
Journal:  J Clin Invest       Date:  1992-12       Impact factor: 14.808

5.  New nucleotide sequence data on the EMBL File Server.

Authors: 
Journal:  Nucleic Acids Res       Date:  1990-11-11       Impact factor: 16.971

6.  Immunoglobulin variable heavy chain cDNA sequence from a patient with X-linked agammaglobulinemia.

Authors:  F Mortari; H D Ochs; R J Wedgwood; H W Schroeder
Journal:  Nucleic Acids Res       Date:  1991-02-11       Impact factor: 16.971

7.  Molecular characterization of five human anti-human immunodeficiency virus type 1 antibody heavy chains reveals extensive somatic mutation typical of an antigen-driven immune response.

Authors:  J S Andris; S Johnson; S Zolla-Pazner; J D Capra
Journal:  Proc Natl Acad Sci U S A       Date:  1991-09-01       Impact factor: 11.205

8.  Two acquired immunodeficiency syndrome-associated Burkitt's lymphomas produce specific anti-i IgM cold agglutinins using somatically mutated VH4-21 segments.

Authors:  P Riboldi; G Gaidano; E W Schettino; T G Steger; D M Knowles; R Dalla-Favera; P Casali
Journal:  Blood       Date:  1994-05-15       Impact factor: 22.113

Review 9.  The molecular structure of human antibodies specific for the human immunodeficiency virus.

Authors:  J S Andris; J D Capra
Journal:  J Clin Immunol       Date:  1995-01       Impact factor: 8.317

10.  Defining the genetic origins of three rheumatoid synovium-derived IgG rheumatoid factors.

Authors:  M Deftos; T Olee; D A Carson; P P Chen
Journal:  J Clin Invest       Date:  1994-06       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.